PTC Inc

PTC Inc

PTC - NASDAQ NMS - GLOBAL MARKET

Industry: Technology

Market Cap: 24.7 B

IPO Date: Dec 8, 1989

Country: US

Currency: USD

Shares Outstanding: 119.8 M

6 month performance

Recent News

PTC Unveils Arena AI Assistant & Supply Chain Intelligence Enhancements

9/19/2025

PTC expands its Arena portfolio with an AI-powered assistant, new supply chain tools and CAD-PLM integration to boost collaboration and efficiency.

News

Source: Yahoo

Is PTC Inc. Stock Underperforming the S&P 500?

9/18/2025

PTC Inc. has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

News

Source: Yahoo

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

9/16/2025

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

News

Source: Yahoo

PTC Launches Arena AI Assistant to Accelerate PLM and QMS Workflows

9/16/2025

PTC (NASDAQ: PTC) today announced the release of its Arena® product lifecycle management (PLM) and quality management system (QMS) Artificial Intelligence (AI) Assistant, enabling teams to accelerate time to value. Arena AI Assistant delivers real-time, context-aware expertise rooted in best practices for PLM and QMS workflows in a conversational interface – helping users navigate engineering change orders, manage corrective and preventive actions (CAPAs), maintain traceability and compliance, a

News

Source: Yahoo

3 Software Stocks to Watch Closely in a Thriving Industry

9/15/2025

Steady digital transformation and strong adoption of AI bode well for Computer Software industry participants like MSFT, PTC and MANH amid broader market volatility.

News

Source: Yahoo

3 Brilliant Growth Stocks to Buy Now and Hold for the Long Term

9/12/2025

These companies are benefiting from exciting megatrends that are here to stay.

News

Source: Yahoo

PTC Inc. stock outperforms competitors on strong trading day

9/11/2025

PTC Inc. stock outperforms competitors on strong trading day

Source: MarketWatch

Cadence Expands Digital Twin Platform With NVIDIA DGX SuperPOD Model

9/10/2025

CDNS expands its Reality Digital Twin Platform with a model of NVIDIA DGX SuperPOD, boosting AI factory and data center design precision.

News

Source: Yahoo

1 Profitable Stock to Consider Right Now and 2 Facing Headwinds

9/10/2025

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".

News

Source: Yahoo

PTC, Agilysys, Elastic, and Guidewire Software Shares Are Falling, What You Need To Know

9/9/2025

A number of stocks fell in the afternoon session after a significant downward revision in U.S. job creation data fueled concerns about a weakening labor market.

News

Source: Yahoo

PTC Inc. stock underperforms Tuesday when compared to competitors

9/9/2025

PTC Inc. stock underperforms Tuesday when compared to competitors

Source: MarketWatch

Nucleus Research Releases 2025 Industrial Internet of Things (IIoT) Data Platform Technology Value Matrix

9/9/2025

The Industrial Internet of Things (IIoT) Data Platform market is moving beyond basic device connectivity to deliver measurable value through advanced data integration, AI, and edge intelligence. Organizations are investing in platforms that unify operational, enterprise, and engineering data into centralized repositories, enabling real-time insights that improve asset performance, reduce downtime, and optimize resource use. This shift reflects a clear focus on ROI, with IIoT platforms increasing

News

Source: Yahoo

PTC (PTC): Evaluating Whether Steady Growth Signals More Upside or a Fully Priced Stock

9/9/2025

PTC (PTC) has been catching some eyes lately, even without a single headline-making event to drive the chatter. Sometimes, it is these quiet stretches that actually make for the most interesting moments, especially for investors wondering whether the current calm is a breather before the next leg up or just the status quo settling in. With the stock market always searching for growth stories, these small moves can prompt investors to take a closer look. Over the past year, PTC’s shares have...

News

Source: Yahoo

Cadence Strengthens Analysis Portfolio With Hexagon D&E Unit Buyout

9/5/2025

CDNS is set to acquire Hexagon's Design & Engineering division for 2.7B euros, expanding its simulation and structural analysis portfolio.

News

Source: Yahoo

RSPT: Technology ETF With Limited Mega-Cap Weight

9/5/2025

Explore the Invesco S&P 500 Equal Weight Technology ETF (RSPT) for balanced tech exposure—learn why its performance may impact your investment choice.

News

Source: SeekingAlpha

2 Reasons to Like PTC (and 1 Not So Much)

9/5/2025

PTC’s 32.1% return over the past six months has outpaced the S&P 500 by 20.8%, and its stock price has climbed to $212.96 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

News

Source: Yahoo

PTC Inc. (PTC) Inc. Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference Transcript

9/4/2025

Discover PTC's latest growth strategies, AI innovation, and PLM leadership

News

Source: SeekingAlpha

Descartes Q2 Earnings Lag, Top Line Up Y/Y Despite Global Trade Woes

9/4/2025

DSGX posts 10% revenue growth and record EBITDA in fiscal Q2 2026, fueled by acquisitions and strong recurring services momentum.

News

Source: Yahoo

Prediction: PTC Will Soar Over the Next 3 Years. Here's 1 Reason Why.

9/2/2025

This software company's underlying growth rate is a lot stronger than the headline numbers indicate.

News

Source: Yahoo

RareMed Announces Expansion of Relationship with PTC Therapeutics

9/2/2025

RareMed Solutions®, the nation's leader in patient support services for complex therapies, is proud to announce an expansion of its relationship with PTC Therapeutics™ with the launch of non-commercial pharmacy dispensing services for PTC's therapy, Sephience™. The recent approval of Sephience by the FDA marks a significant milestone in the treatment of phenylketonuria (PKU) for both adult and pediatric patients. This new therapy, developed by PTC, has the potential to transform the lives of tho

News

Source: Yahoo